Evaluating Avacopan in the Treatment of ANCA-Associated Vasculitis: Design, Development and Positioning of Therapy
Jolijn R van Leeuwen,1 Luca Quartuccio,2 Juliana Bordignon Draibe,3 Iva Gunnarson,4 Ben Sprangers,5 Y K Onno Teng1 1Center of Expertise for Lupus-, Vasculitis- and Complement-Mediated Systemic Diseases (Luvacs), Department of Internal Medicine - Nephrology Section, Leiden University Medical Center,...
Saved in:
| Main Authors: | van Leeuwen JR, Quartuccio L, Draibe JB, Gunnarson I, Sprangers B, Teng YKO |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-01-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/evaluating-avacopan-in-the-treatment-of-anca-associated-vasculitis-des-peer-reviewed-fulltext-article-DDDT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PROBLEMS IN THE DIAGNOSIS AND TREATMENT OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS: IN THE FOCUS OF ANCA-NEGATIVE PAUCI-IMMUNE GLOMERULONEPHRITIS
by: T. V. Beketova, et al.
Published: (2016-12-01) -
Applications and challenges of glucocorticoids for anti-neutrophil cytoplasmic antibody-associated vasculitis
by: Wen Kai-lian, et al.
Published: (2022-12-01) -
Avacopan in Anti-Neutrophil Cytoplasmic Autoantibodies–Associated Vasculitis in a Real-World Setting
by: Jonas Zimmermann, et al.
Published: (2024-09-01) -
Clinicopathological Spectrum and Outcome of Crescentic Glomerulonephritis: A Retrospective Study from North-East India
by: Manzoor Ahmad Parry, et al.
Published: (2022-01-01) -
Predictors of renal outcome in ANCA-assosiated glomerulonephritis
by: Ljubičić Bojana, et al.
Published: (2021-01-01)